rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2010-11-10
|
pubmed:abstractText |
Combination of bevacizumab and FOLFIRI has currently become one of the standard therapeutic regimens. However, published information is still limited. The objective of the present retrospective observational study is to analyse the response and toxicity of first-line treatment with FOLFIRI+bevacizumab in patients with metastatic colorectal cancer (mCRC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1532-1827
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
9
|
pubmed:volume |
103
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1536-41
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20940719-Aged,
pubmed-meshheading:20940719-Antibodies, Monoclonal,
pubmed-meshheading:20940719-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:20940719-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20940719-Camptothecin,
pubmed-meshheading:20940719-Colonic Neoplasms,
pubmed-meshheading:20940719-Colorectal Neoplasms,
pubmed-meshheading:20940719-Disease Progression,
pubmed-meshheading:20940719-Drug Tolerance,
pubmed-meshheading:20940719-Female,
pubmed-meshheading:20940719-Fluorouracil,
pubmed-meshheading:20940719-Humans,
pubmed-meshheading:20940719-Leucovorin,
pubmed-meshheading:20940719-Liver Neoplasms,
pubmed-meshheading:20940719-Male,
pubmed-meshheading:20940719-Middle Aged,
pubmed-meshheading:20940719-Neoplasm Metastasis,
pubmed-meshheading:20940719-Rectal Neoplasms,
pubmed-meshheading:20940719-Retrospective Studies,
pubmed-meshheading:20940719-Safety,
pubmed-meshheading:20940719-Spain,
pubmed-meshheading:20940719-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer.
|
pubmed:affiliation |
Department of Oncology, Complejo Hospitalario Universitario de Santiago, Travesía da Choupana, s/n, 15706 Santiago de Compostela, Spain. rafa.lopez.lopez@gmail.com
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|